MEDITEC MEL 80 EXCIMER LASER SYSTEM

FDA Premarket Approval P060004 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the mel 80 excimer laser system. This device uses an optical zone of 6. 0 to 6. 5 mm in diameter and a transition zone of 2. 0 to 4. 0 mm for a total ablation diameter of 10. 0 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of naturally-occurring hyperopia of less than or equal to +5. 0 d with or without refractive astigmatism of > +0. 5 and

DeviceMEDITEC MEL 80 EXCIMER LASER SYSTEM
Generic NameExcimer Laser System
ApplicantCarl Zeiss Meditec, Inc.
Date Received2007-12-28
Decision Date2011-03-28
Notice Date2011-04-25
PMAP060004
SupplementS001
Product CodeLZS 
Docket Number11M-0256
Advisory CommitteeOphthalmic
Supplement TypePanel Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address Carl Zeiss Meditec, Inc. 5160 Hacienda Drive dublin, CA 94568
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P060004Original Filing
S002 2008-01-18 30-day Notice
S001 2007-12-28 Panel Track

NIH GUDID Devices

Device IDPMASupp
04049471000221 P060004 001
04049471095074 P060004 006

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.